Paclitaxel Injection, Solution
Product Images NDC 72162-2640

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Paclitaxel (NDC 72162-2640). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fig-1 (Figure 1)

Fig-1 (Figure 1)
FDA Label Image

Fig-2 (Figure 2)

Fig-2 (Figure 2)
This text appears to be a statistical output possibly related to survival analysis. It provides data on the number of events, hazard ratio, and the number at risk over different time intervals. The data seems to be organized in a table format with details on the proportion of survival at specific time points. The text also includes information on the number of individuals at risk and the number of events that occurred over time.*
FDA Label Image

Fig-3 (Figure 3)

Fig-3 (Figure 3)
Proportion Disease Free at 2 years is 32%.*
FDA Label Image

Fig-4 (Figure 4)

Fig-4 (Figure 4)
FDA Label Image

Fig-5 (Figure 5)

Fig-5 (Figure 5)
PROPORTION DISEASE FREE in 2020 is 2%.*
FDA Label Image

Fig-6 (Figure 6)

Fig-6 (Figure 6)
This text seems to be a data table showing the proportion of disease-free individuals at different time points or years. It displays numbers related to the risk factors and possible events to determine the disease-free rate over time.*
FDA Label Image

Fig-7 (Figure 7)

Fig-7 (Figure 7)
This text provides information on the proportion of disease-free individuals over a period of time. It includes the number of participants at risk, events observed, hazard ratio (HR), confidence intervals, and years studied. These details are essential for analyzing disease progression and prevention strategies.*
FDA Label Image

Fig-8 (Figure 8)

Fig-8 (Figure 8)
This text provides data on the proportion of disease-free individuals in a study focusing on treatment labeled as AC+T. The information includes the number of events, hazard ratio, 95% confidence interval, and the number at risk for both AC+T and AC treatments over a period of years.*
FDA Label Image

Label (Lbl721622640)

Label (Lbl721622640)
This is a description of a pharmaceutical product containing 6 mg of Paclitaxel per mL. The formulation also includes polyoxyl 35 castor oil, dehydrated alcohol, and citric acid. The recommended storage conditions are between 20°C to 25°C to protect from light. The product is a cytotoxic agent and requires dilution before intravenous infusion. Gloves should be worn when handling the product, and it should be kept out of reach of children. Further detailed dosage and usage instructions can be found by scanning the QR code on the package insert.*
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.